Operating revenue reached $523.8m and net profit after tax was $16.0m, with pharmacy and medical divisions showing mixed performance amid economic headwinds. A final dividend of 2.75 cents per share was declared.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.